Rojkjaer Lisa has filed 7 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 18894 shares of RIGEL PHARMACEUTICALS INC ($RIGL) on February 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | Rojkjaer Lisa | EVP, Chief Medical Officer | A | Common Stock | 18894 | $0.00 | 34,853.0000 | 18,840,000 | 118.39% | 0.10% |
| Feb. 10, 2026 | RIGEL PHARMACEUTICALS INC | $RIGL | Rojkjaer Lisa | EVP, Chief Medical Officer | F | Common Stock | 3758 | $34.62 | 15,959.0000 | 18,840,000 | 19.06% | 0.02% |
| Sept. 15, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Rojkjaer Lisa | EVP, Chief Medical Officer | A | Employee Stock Option (right to buy) | 7394 | $0.00 | 7,394.0000 | 18,162,000 | 9999.99% | 0.04% |
| March 17, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Rojkjaer Lisa | EVP, Chief Medical Officer | A | Employee Stock Option (right to buy) | 9375 | $0.00 | 9,375.0000 | 17,687,000 | 9999.99% | 0.05% |
| Jan. 29, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Rojkjaer Lisa | EVP, Chief Medical Officer | A | Common Stock | 19717 | $0.00 | 19,717.0000 | 17,687,000 | 9999.99% | 0.11% |
| Jan. 29, 2025 | RIGEL PHARMACEUTICALS INC | $RIGL | Rojkjaer Lisa | EVP, Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 14788 | $0.00 | 14,788.0000 | 17,687,000 | 9999.99% | 0.08% |
| March 27, 2024 | RIGEL PHARMACEUTICALS INC | $RIGL | Rojkjaer Lisa | EVP, Chief Medical Officer | A | Employee Stock Option (right to buy) | 187500 | $0.00 | 187,500.0000 | 17,401,000 | 9999.99% | 1.08% |